Use of tryptanthrin compounds for immune potentiation
申请人:Chiron Corporation
公开号:US20040241192A1
公开(公告)日:2004-12-02
The invention provides immunostimulatory compositions and methods of administration thereof. Also provided are methods of administering a tryptanthrin compound in an effective amount to enhance the immune response of a subject to an antigen. Also provided are methods of administering an effective amount of a tryptanthrin to stimulate the immune response in a subject for the treatment of cancer. Further provided are methods of administering a tryptanthrin compounds as an immunotherapeutic in the treatment of infectious diseases.
USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION
申请人:VALIANTE Nicholas M.
公开号:US20120244182A1
公开(公告)日:2012-09-27
The invention provides immunostimulatory compositions and methods of administration thereof. Also provided are methods of administering a tryptanthrin compound in an effective amount to enhance the immune response of a subject to an antigen. Also provided are methods of administering an effective amount of a tryptanthrin to stimulate the immune response in a subject for the treatment of cancer. Further provided are methods of administering a tryptanthrin compounds as an immunotherapeutic in the treatment of infectious diseases.
[EN] USE OF TRYPTANTHRIN COMPOUNDS FOR IMMUNE POTENTIATION<br/>[FR] UTILISATION DE COMPOSES DE TRYPTANTHRINE DANS LA POTENTIALISATION IMMUNOLOGIQUE
申请人:CHIRON CORP
公开号:WO2004064759A2
公开(公告)日:2004-08-05
The invention provides immunostimulatory compositions and methods of administration thereof. Also provided are methods of administering a tryptanthrin compound in an effective amount to enhance the immune response of a subject to an antigen. Also provided are methods of administering an effective amount of a tryptanthrin to stimulate the immune response in a subject for the treatment of cancer. Further provided are methods of administering a tryptanthrin compounds as an immunotherapeutic in the treatment of infectious diseases.